文献速递心脑血管急症

连续常规肌钙蛋白检测在急诊科按HEART评分和症状时间分层患者中的应用价值

Utility of serial conventional troponin testing for emergency department patients stratified by HEART score and symptom timing.
PubMed 文献 · Am J Emerg Med · 2023-05-01
一句话结论低危HEART评分患者复查3小时肌钙蛋白I阳性率仅1.1%,作者认为获益有限;中高危尤其症状3小时内就诊者可能更有用。

本研究为回顾性队列研究,纳入944例完成HEART评分的连续成人急诊胸痛患者,评估3小时复查肌钙蛋白I(ΔTnI)按HEART评分和症状时间分层的阳性率及6周主要不良心脏事件(MACE)。433例(45.9%)为低危HEART评分0-3分,其中268例(61.9%)复查TnI者仅3例(1.1%,[0.2-3.2%])ΔTnI阳性,1例伴初始TnI升高。症状3小时内就诊者ΔTnI阳性率、就诊时MACE和6周MACE均高于症状≥3小时及时间不明者。作者认为低危患者连续检测获益有限,中高危尤其3小时内就诊者可能有用。

要点

  • 低危HEART评分0-3分患者中,复查3小时TnI者268例,仅3例(1.1%,[0.2-3.2%])ΔTnI阳性,其中1例初始TnI已升高。
  • 症状3小时内就诊者ΔTnI阳性率15.9%,高于症状≥3小时的11.0%和时间不明的10.3%(p < 0.001)。
  • 症状3小时内就诊者就诊时MACE 10.0%,高于症状≥3小时的5.3%和时间不明的4.6%(p = 0.021)。
  • 症状3小时内就诊者6周MACE 12.7%,高于症状≥3小时的6.6%和时间不明的6.4%(p = 0.047)。
  • 作者认为低危HEART评分患者无论症状持续时间如何,连续常规肌钙蛋白检测的额外获益有限;中高危患者尤其症状3小时内就诊者可能有用。

适用人群与场景

  • 急诊科连续成人胸痛患者,已完成完整HEART评分,疑似急性冠脉综合征(ACS)。

诊断标准与关键阈值

  • HEART评分0-3分为低危,共433例(45.9%)。
  • ΔTnI定义为第二次TnI减初始TnI,阳性即ΔTnI阳性。

处置流程与药物剂量

  • 初始检测常规肌钙蛋白I后,3小时复查第二次常规肌钙蛋白I,计算ΔTnI。
  • 低危HEART评分0-3分患者中268例(61.9%)接受了第二次TnI检测。

研究设计与关键结果

  • 回顾性队列研究,纳入944例连续成人急诊患者,433例(45.9%)为低危HEART评分0-3分。
  • 低危患者中268例(61.9%)复查TnI,仅3例(1.1%,[0.2-3.2%])ΔTnI阳性,其中1例初始TnI升高。
  • 症状3小时内就诊者ΔTnI阳性率15.9%,症状≥3小时者11.0%,时间不明者10.3%(p < 0.001)。
  • 症状3小时内就诊者就诊时MACE 10.0%,症状≥3小时者5.3%,时间不明者4.6%(p = 0.021)。
  • 症状3小时内就诊者6周MACE 12.7%,症状≥3小时者6.6%,时间不明者6.4%(p = 0.047)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,低危HEART评分患者连续常规肌钙蛋白检测的额外获益有限,无论症状持续时间和时机如何。
  • 作者认为,中高危HEART评分患者连续肌钙蛋白检测可能有用,尤其症状3小时内就诊者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The HEART score for risk stratifying chest pain patients in the emergency department (ED) has been widely adopted in clinical practice, but is often employed with nonconformant serial troponin measurements.

OBJECTIVE: The primary objective of this study was to examine the utility of obtaining a second conventional 3-h troponin I (TnI) level in ED patients presenting with potential acute coronary syndrome (ACS), stratified by HEART score and duration of symptoms.

METHODS: This was a retrospective cohort study of consecutive adult ED patients with a complete HEART score. We assessed the utility of repeat TnI measurement by examining the positivity rate of ΔTnI = [Second TnI] - [Initial TnI] stratified by HEART score and time elapsed since onset or resolution of symptoms. Major adverse cardiac events (MACE) within 6 weeks of index visit were assessed.

RESULTS: A total of 944 patients were included with 433 (45.9%) assigned a low risk HEART score 0-3. Of the 268 (61.9%) low risk HEART score patients receiving a second TnI, only 3 (1.1%, [0.2-3.2%]) resulted in a positive ΔTnI, one of which occurred in the setting of an elevated initial TnI. Overall, patients presenting within 3 h of symptoms were more likely to experience positive ΔTnI, index MACE and MACE at 6 weeks compared to patients presenting ≥3 h since symptoms onset/resolution and patients with unknown timing of symptoms (15.9% vs 11.0% vs 10.3%, p < 0.001; 10.0% vs 5.3% vs 4.6%, p = 0.021; 12.7% vs 6.6% vs 6.4%, p = 0.047).

CONCLUSION: Our data suggest serial measurement of conventional troponin provides limited added benefit in low risk HEART score patients, regardless of duration and timing of symptoms. Conversely, serial troponin measurement may confer utility in moderate/high risk HEART score patients, particularly those presenting within 3 h of symptoms.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Reyes J, Becker BA, D'Angelo J, et al. Utility of serial conventional troponin testing for emergency department patients stratified by HEART score and symptom timing. Am J Emerg Med. 2023. PMID: 37149957. doi:10.1016/j.ajem.2023.04.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。